Pfizer Metsera Acquisition: What It Means for Patients and the Future of Weight Loss

Pfizer wins the $10B bid for Metsera, opening new avenues for obesity treatment and addressing unmet healthcare needs with ...

Pfizer Wins Obesity Drug Prize, With Trump Administration Assist

Pfizer Inc. Chief Executive Albert Bourla had long searched for an obesity drug to make up for dwindling sales of the pharma ...
Zacks Investment Research on MSN

Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?

As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...
pharmaphorum

Pfizer, Metsera $10bn marriage back on after rough patch

Metsera said it expects the Pfizer deal to close promptly after a stockholder meeting scheduled for this coming Thursday ...